Valeo Pharma Launches Redesca and Redesca HP (LMHW biosimilar) in Canada

Shots:

• Valeo has started commercial shipment of Redesca and Redesca HP, its low molecular weight heparin (“LMWH”) biosimilar across Canada
• The LMWH is being used primarily for treating and preventing deep vein thrombosis and pulmonary embolism and is now increasingly used as a 1L of defense tool in the fight against COVID-19
• Redesca is a low molecular weight heparin biosimilar

Click here to­ read full press release/ article | Ref: PRNewswire | Image: Valeo